Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action-Reference-Cited by-同舟云学术

Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action

Published:2020-04-29 Issue:6 Volume:37 Page:2575-2579
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Khan Zakir^ORCID,Karataş Yusuf,Rahman Hazir

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-020-01351-9.pdf

Reference31 articles.

1. World Health Organization (WHO). Coronavirus. 2020. https://www.who.int/health-topics/coronavirus. Accessed 23 Mar 2020.

2. Centers for Disease Control and Prevention (CDC). Coronavirus symptoms and diagnosis. 2020. https://www.cdc.gov/coronavirus/about/symptoms.html. Accessed 23 Mar 2020.

3. Khan Z, Muhammad K, Ahmed A, Rahman H. Coronavirus outbreaks: prevention and management recommendations. Drugs Ther Perspect. 2020. https://doi.org/10.1007/s40267-020-00717-x.

4. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) situation report—50. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200310-sitrep-50-covid-19.pdf?sfvrsn=55e904fb_2. Accessed 24 Mar 2020.

5. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19) situation report—84. 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200413-sitrep-84-covid-19.pdf?sfvrsn=44f511ab_2. Accessed 14 Apr 2020.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer Aided Structure-Based Drug Design of Novel SARS-CoV-2 Main Protease Inhibitors: Molecular Docking and Molecular Dynamics Study;Computation;2024-01-20

2. Passive antibody therapy in emerging infectious diseases;Frontiers of Medicine;2023-12-02

3. Recent Advances on the Synthesis of Orally Active Antiviral Drug Molnupiravir;Current Organic Chemistry;2023-11

4. Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement;Inflammopharmacology;2023-07-12

5. Repurposing Remdesivir for COVID-19: Computational Drug Design Targeting SARS-CoV-2 RNA Polymerase and Main Protease using Molecular Dynamics Approach;2023-06-16